Jiangxi Rimag Group Co Ltd (Ticker: 2522 HK) is a healthcare company that operates medical imaging centers in China. Jiangxi Rimag Group will list on June 7 on the Hong Kong Stock Exchange. The firm is selling 17.8 million primary shares at the price range of HK$14.60 to HK$16.80 per share, aiming to raise up to HK$299 million (USD 38 million). The IPO is managed by Citic Securities as the sponsor, with several joint book runners including CLSA Asia-Pacific Markets, CMB International Capital, and Huatai Financial Holdings. Three cornerstone investors are participating with a combined investment of HK$121 million.